# Neural Stem Cell Treatment for Amyotrophic Lateral Sclerosis (STEMALS)

> **NCT06344260** · PHASE2 · RECRUITING · sponsor: **Casa Sollievo della Sofferenza IRCCS** · enrollment: 30 (estimated)

## Conditions studied

- Amyotrophic Lateral Sclerosis

## Interventions

- **PROCEDURE:** human Neural Stem Cells (hNSC)
- **PROCEDURE:** Saline (Placebo)

## Key facts

- **NCT ID:** NCT06344260
- **Lead sponsor:** Casa Sollievo della Sofferenza IRCCS
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-01-25
- **Primary completion:** 2027-03
- **Final completion:** 2027-09
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2024-04-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06344260

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06344260, "Neural Stem Cell Treatment for Amyotrophic Lateral Sclerosis (STEMALS)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06344260. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*